- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有230家主力机构披露2025-12-31报告期持股数据，持仓量总计1.99亿股，占流通A股44.39%
- 波段诊断：
-
技术面诊股
诊断结果：2.7技术面打败了17%的股票
技术面评分前10的股票
近期的平均成本为35.17元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为35.17元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"35.17","date":1780475915,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.06.04","stock":"-1.42","trade":"-1.37","ind":"-0.64"},{"date":"2026.06.03","stock":"-4.27","trade":"-1.00","ind":"0.22"},{"date":"2026.06.02","stock":"-1.97","trade":"-1.85","ind":"0.43"},{"date":"2026.06.01","stock":"0.37","trade":"-0.06","ind":"-0.27"},{"date":"2026.05.29","stock":"2.72","trade":"-1.55","ind":"-0.73"},{"date":"2026.05.28","stock":"-2.36","trade":"0.01","ind":"0.12"},{"date":"2026.05.27","stock":"2.47","trade":"-1.47","ind":"-1.25"},{"date":"2026.05.26","stock":"-0.63","trade":"-1.68","ind":"-0.17"},{"date":"2026.05.25","stock":"-1.00","trade":"-0.77","ind":"0.96"},{"date":"2026.05.22","stock":"0.76","trade":"0.16","ind":"0.87"},{"date":"2026.05.21","stock":"-0.24","trade":"-1.29","ind":"-2.04"},{"date":"2026.05.20","stock":"-3.41","trade":"-0.55","ind":"-0.18"},{"date":"2026.05.19","stock":"-1.27","trade":"0.38","ind":"0.92"},{"date":"2026.05.18","stock":"-2.99","trade":"-0.52","ind":"-0.09"},{"date":"2026.05.15","stock":"0.35","trade":"-0.48","ind":"-1.02"},{"date":"2026.05.14","stock":"-3.06","trade":"-2.84","ind":"-1.52"},{"date":"2026.05.13","stock":"-0.58","trade":"-0.26","ind":"0.67"},{"date":"2026.05.12","stock":"-1.95","trade":"-1.64","ind":"-0.25"},{"date":"2026.05.11","stock":"1.48","trade":"1.93","ind":"1.08"},{"date":"2026.05.08","stock":"-1.01","trade":"-0.14","ind":"-0.00"},{"date":"2026.05.07","stock":"-1.51","trade":"0.54","ind":"0.48"}]
通策医疗,上证指数,医疗服务指数
压力支撑
该股压力位为35.20元，支撑位为34.49元。
[{"text":"\u538b\u529b\u4f4d","value":"35.20","date":1780502400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"34.49","date":1780502400,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.7资金面打败了2%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月04日 20:31
| 机构今日流向(万元) | -897.53 | 机构5日流向(万元) | -3782.41 |
| 机构10日流向(万元) | -11048.71 | 机构20日流向(万元) | -29489.97 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2326.73万股，其中基金净减仓84家，主力净减仓29家，请投资者中长期谨慎为宜。
截止2025-12-31，共230家主力机构（基金227家，一般法人3家），持仓量总计19856.67万股，占流通A股44.39%
其中，基金持仓与2025-06-30相比：
增仓：36家 ，增持 157.76万股
减仓：120家 ，减持 766.78万股
新出现在主力名单中：55家 ，持有169.06万股
从主力名单中消失：84家 ，原持有1428.74万股
其中，基金持仓与2025-06-30相比：
增仓：36家 ，增持 157.76万股
减仓：120家 ，减持 766.78万股
新出现在主力名单中：55家 ，持有169.06万股
从主力名单中消失：84家 ，原持有1428.74万股
消息面诊股
诊断结果：5.5消息面打败了52%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 通策医疗：6月3日获融资买入3173.32万元
2026-06-04 - 智享生物递表港交所；生物股份董事长提议以2亿元—4
2026-06-04 - 通策医疗：拟以5000万元-1亿元回购公司股份
2026-06-03 - 通策医疗：6月2日获融资买入1589.15万元
2026-06-03 - 通策医疗：6月1日获融资买入2182.30万元
2026-06-02 - 通策医疗：5月29日获融资买入2557.13万元
2026-05-30 - 通策医疗：公司主业经营、基本面未发生重大变化
2026-05-29 - 通策医疗（截止2026年5月20日）股东人数为90
2026-05-29 - 通策医疗：5月28日获融资买入2107.60万元
2026-05-29 - 蛰伏三年谋变局：通策医疗或接棒和仁科技，控制权拉锯
2026-05-28
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-18 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-03-25 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-25 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-06 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-12 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：4.8行业面打败了72%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.06.04","price":"-0.64","value":"-1.37"},{"date":"2026.06.03","price":"0.22","value":"-1.00"},{"date":"2026.06.02","price":"0.43","value":"-1.85"},{"date":"2026.06.01","price":"-0.27","value":"-0.06"},{"date":"2026.05.29","price":"-0.73","value":"-1.55"},{"date":"2026.05.28","price":"0.12","value":"0.01"},{"date":"2026.05.27","price":"-1.25","value":"-1.47"},{"date":"2026.05.26","price":"-0.17","value":"-1.68"},{"date":"2026.05.25","price":"0.96","value":"-0.77"},{"date":"2026.05.22","price":"0.87","value":"0.16"},{"date":"2026.05.21","price":"-2.04","value":"-1.29"},{"date":"2026.05.20","price":"-0.18","value":"-0.55"},{"date":"2026.05.19","price":"0.92","value":"0.38"},{"date":"2026.05.18","price":"-0.09","value":"-0.52"},{"date":"2026.05.15","price":"-1.02","value":"-0.48"},{"date":"2026.05.14","price":"-1.52","value":"-2.84"},{"date":"2026.05.13","price":"0.67","value":"-0.26"},{"date":"2026.05.12","price":"-0.25","value":"-1.64"},{"date":"2026.05.11","price":"1.08","value":"1.93"},{"date":"2026.05.08","price":"-0.00","value":"-0.14"},{"date":"2026.05.07","price":"0.48","value":"0.54"}]
上证指数,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华康洁净 | 26.49% | 3.02% | 6.1分 |
| 2 | 皓元医药 | 3.61% | 0.77% | 5.6分 |
| 3 | ST中珠 | 3.05% | 3.45% | 4.9分 |
| 4 | 百诚医药 | 0.74% | -8.82% | 5.3分 |
| 5 | 百奥赛图 | -2.26% | -14.80% | 5.5分 |
| 6 | *ST生物 | -3.65% | -7.14% | 5.1分 |
| 8 | 华厦眼科 | -7.07% | -3.24% | 5.2分 |
| 10 | 成都先导 | -8.85% | -11.20% | 5.0分 |
| 12 | 美迪西 | -9.10% | -8.77% | 5.5分 |
| 14 | 九洲药业 | -9.53% | -1.12% | 5.0分 |
| 16 | - | -9.97% | -1.49% | 分 |
| 18 | 国际医学 | -11.66% | -4.44% | 4.1分 |
| 20 | 和元生物 | -12.24% | -1.18% | 3.9分 |
| 22 | 皓宸医疗 | -12.81% | -6.13% | 5.0分 |
| 24 | 大湖股份 | -13.98% | -2.58% | 4.4分 |
| 26 | 澳洋健康 | -14.63% | -4.75% | 4.3分 |
| 28 | 昭衍新药 | -15.11% | -8.34% | 4.8分 |
| 30 | 药石科技 | -15.35% | -7.34% | 4.1分 |
| 32 | 博济医药 | -15.94% | -12.03% | 4.0分 |
| 34 | 华大基因 | -16.16% | -6.36% | 4.6分 |
| 36 | 三博脑科 | -16.88% | -5.83% | 4.5分 |
| 38 | 光正眼科 | -17.00% | -5.84% | 5.1分 |
| 40 | 药康生物 | -17.43% | -13.73% | 4.8分 |
| 42 | 康龙化成 | -18.13% | -8.15% | 5.0分 |
| 44 | 金凯生科 | -19.25% | -4.23% | 4.3分 |
| 46 | 南模生物 | -20.37% | -8.09% | 4.4分 |
| 48 | 泓博医药 | -21.98% | -5.00% | 4.3分 |
| 50 | 普瑞眼科 | -24.28% | -12.13% | 5.0分 |
| 52 | 泰格医药 | -25.50% | 0.87% | 4.7分 |
| 54 | 创新医疗 | -27.66% | -17.11% | 4.7分 |
| 56 | 博腾股份 | -32.92% | -5.67% | 4.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/102 ， 16/102。
[{"date":"2026-03-31","value":"4.32","vol":"0.96"},{"date":"2025-12-31","value":"12.15","vol":"2.21"},{"date":"2025-09-30","value":"12.27","vol":"3.24"},{"date":"2025-06-30","value":"7.85","vol":"2.24"},{"date":"2025-03-31","value":"4.47","vol":"0.88"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.32 | 12.15 | 12.27 | 7.85 | 4.47 |
| 行业(%) | 0.96 | 2.21 | 3.24 | 2.24 | 0.88 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"43.87","vol":"34.16"},{"date":"2025-12-31","value":"38.63","vol":"34.36"},{"date":"2025-09-30","value":"41.69","vol":"36.06"},{"date":"2025-06-30","value":"40.75","vol":"36.21"},{"date":"2025-03-31","value":"44.21","vol":"35.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
43.87 | 38.63 | 41.69 | 40.75 | 44.21 |
| 行业(%) | 34.16 | 34.36 | 36.06 | 36.21 | 35.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 34/102 ， 34/102。
[{"date":"2026-03-31","value":"1.43","vol":"16.75"},{"date":"2025-12-31","value":"1.37","vol":"8.22"},{"date":"2025-09-30","value":"2.56","vol":"3.06"},{"date":"2025-06-30","value":"2.68","vol":"2.87"},{"date":"2025-03-31","value":"5.11","vol":"-0.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.43 | 1.37 | 2.56 | 2.68 | 5.11 |
| 行业(%) | 16.75 | 8.22 | 3.06 | 2.87 | -0.73 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.66","vol":"79.49"},{"date":"2025-12-31","value":"0.19","vol":"23.26"},{"date":"2025-09-30","value":"3.16","vol":"20.05"},{"date":"2025-06-30","value":"3.67","vol":"-63.31"},{"date":"2025-03-31","value":"6.22","vol":"-22.07"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
1.66 | 0.19 | 3.16 | 3.67 | 6.22 |
| 行业(%) | 79.49 | 23.26 | 20.05 | -63.31 | -22.07 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/102 ， 3/102。
[{"date":"2026-03-31","value":"0.12","vol":"0.10"},{"date":"2025-12-31","value":"0.48","vol":"0.44"},{"date":"2025-09-30","value":"0.37","vol":"0.32"},{"date":"2025-06-30","value":"0.23","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.48 | 0.37 | 0.23 | 0.12 |
| 行业(次) | 0.10 | 0.44 | 0.32 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"18.93","vol":"3.44"},{"date":"2025-12-31","value":"71.86","vol":"15.84"},{"date":"2025-09-30","value":"42.81","vol":"10.95"},{"date":"2025-06-30","value":"28.10","vol":"7.15"},{"date":"2025-03-31","value":"14.17","vol":"3.62"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
18.93 | 71.86 | 42.81 | 28.10 | 14.17 |
| 行业(次) | 3.44 | 15.84 | 10.95 | 7.15 | 3.62 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"21.31","vol":"0.86"},{"date":"2025-12-31","value":"20.73","vol":"20.95"},{"date":"2025-09-30","value":"38.71","vol":"16.52"},{"date":"2025-06-30","value":"29.57","vol":"16.38"},{"date":"2025-03-31","value":"19.84","vol":"-0.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 21.31 | 20.73 | 38.71 | 29.57 | 19.84 |
| 行业 | 0.86 | 20.95 | 16.52 | 16.38 | -0.79 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.93","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.11","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.93 | - | 1.11 | - |
| 行业 | 0.00 | 0.89 | 0.01 | 0.91 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 14/102 ， 18/102。
[{"date":"2026-03-31","value":"1.71","vol":"3.37"},{"date":"2025-12-31","value":"1.49","vol":"3.64"},{"date":"2025-09-30","value":"1.62","vol":"3.67"},{"date":"2025-06-30","value":"1.28","vol":"3.57"},{"date":"2025-03-31","value":"1.61","vol":"3.68"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.71 | 1.49 | 1.62 | 1.28 | 1.61 |
| 行业 | 3.37 | 3.64 | 3.67 | 3.57 | 3.68 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.58","vol":"2.78"},{"date":"2025-12-31","value":"1.38","vol":"3.00"},{"date":"2025-09-30","value":"1.47","vol":"2.94"},{"date":"2025-06-30","value":"1.15","vol":"2.87"},{"date":"2025-03-31","value":"1.48","vol":"2.97"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.58 | 1.38 | 1.47 | 1.15 | 1.48 |
| 行业 | 2.78 | 3.00 | 2.94 | 2.87 | 2.97 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 32/102 ， 34/102。
[{"date":"2026-03-31","value":"23.29","vol":"32.97"},{"date":"2025-12-31","value":"24.38","vol":"32.98"},{"date":"2025-09-30","value":"25.10","vol":"32.60"},{"date":"2025-06-30","value":"27.51","vol":"33.58"},{"date":"2025-03-31","value":"26.97","vol":"32.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.29 | 24.38 | 25.10 | 27.51 | 26.97 |
| 行业(%) | 32.97 | 32.98 | 32.60 | 33.58 | 32.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.33","vol":"0.97"},{"date":"2025-12-31","value":"0.35","vol":"0.97"},{"date":"2025-09-30","value":"0.36","vol":"0.92"},{"date":"2025-06-30","value":"0.41","vol":"0.96"},{"date":"2025-03-31","value":"0.40","vol":"0.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.33 | 0.35 | 0.36 | 0.41 | 0.40 |
| 行业(%) | 0.97 | 0.97 | 0.92 | 0.96 | 0.96 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2026-05-18 | 买入 | |
| 兴业证券 | 2026-05-15 | 增持 | |
| 华安证券 | 2026-05-13 | 买入 | |
| 华创证券 | 2026-05-07 | 买入 | |
| 国泰海通证券 | 2026-05-04 | 买入 | |
| 中信证券 | 2026-04-30 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"5.48","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.01","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.02","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"5.91","blueLineValue":"1.32","type":"YC"}]